Published Date: 02 Mar 2023
The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.
Read Full NewsResearchers compare enzalutamide vs abiraterone in the metastatic castration-sensitive prostate cancer setting.
A new study assesses breast and ovarian cancer risk in women who carry a BRCA variant of uncertain significance or have a noninformative negative result.
1.
Clinical trial is testing whether heavy lifting could combat cancer side effects
2.
New Gene Therapy Nears EU Nod for Bladder Cancer
3.
June 20, 2023, Health Bulletin No. 12.
4.
'Cell-in-cell' mechanism explains how blood cancer uses bone marrow to evade treatment
5.
Have the Harms of Lung Cancer Screening Been Exaggerated?
1.
The Power of White Blood Cells: How They Help Keep Us Healthy
2.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
3.
Citizen-Centered Digital Health Navigation Systems: Advancing Patient Engagement and Optimizing Healthcare Delivery
4.
Advancements in Squamous Cell Carcinoma Treatment: Decoding Survival Strategies and Molecular Pathways to Improve Cure Rates
5.
Recombinant ADAMTS13: Advancing Prophylaxis in Congenital TTP Management
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
1.
A New Era in Managing Cancer-Associated Thrombosis
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
3.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
5.
Navigating the Complexities of Ph Negative ALL - Part XIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation